Newsroom

BioCentury Article: Cell and gene therapy must prioritize simplification, standardization before focusing on automation

Josh Ludwig, Global Director of Commercial Operations at ScaleReady, reviews how the industry is addressing the challenges that come with...

For the Record - Medical Alley Interview with Josh Ludwig

Catch up with the editors from Medical Alley as they interview ScaleReady Global Commercial Director, Josh Ludwig for their regular...

CancerNetworks Interviews ScaleReady

Josh Ludgwig, Global Director of Commercial Operations at ScaleReady discusses what makes the company uniquely positioned to support manufacturing across...

ScaleReady Joins the Alliance for Regenerative Medicine

As a member of The Alliance for Regenerative Medicine (ARM), ScaleReady committed to progressing regenerative medicine and advanced therapy manufacturing...

RegMedNet interviews Josh Ludwig, Global Commercial Director

In this interview, Josh Ludwig, Global Director of Commercial Operations at ScaleReady, describes how a scalable, cost-effective and practical manufacturing...